. In what ways, if any, should the stakeholders in the U.S. opioid...

. In what ways, if any, should the stakeholders in the U.S. opioid crisis bear responsibility? Are there any changes to the industry actors' CSR strategy that you would suggest? If some shareholders complained that the pharmaceutical industry has been spending

too little or too much effort on corporate social responsibility, what would you tell them?